Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline, Am J Respir Crit Care Med. 2020 May 1;201(9):e56-e69. doi: 10.1164/rccm.202003-0625ST.

Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. Rabe KF, Martinez FJ, Ferguson GT, et al, for the ETHOS Investigators. N Engl J Med 2020;383(1):35-48.

Protocole médical traitement pharmacologique Exacerbation MPOC présumée bactérienne, INESS, ordonnance collective

Exacerbation aiguë de la MPOC, INESS, juin 2017

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline, Eur Respir J 2017; 49: 1600791 [].

Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic Review, Rockville (MD): Agency for Healthcare Research and Quality (US); 2019 Oct. Report No.: 19(20)-EHC024-EF

Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis, Ann Intern Med. 2020 Mar 17;172(6):413-422. doi: 10.7326/M19-3007. Epub 2020 Feb 25.

Nebulized terbutaline & ipratropium bromide vs terbutaline alone in acute exacerbation of COPD requiring noninvasive ventilation: a randomized double blind controlled trial, Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 2018 August 29

Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease, Cochrane Airways Group, First published: 13 July 2017